Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2002;90:380-389
doi: 10.1161/hh0402.105757
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lopez, M. F.
Right arrow Articles by Melov, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lopez, M. F.
Right arrow Articles by Melov, S.
Related Collections
Right arrow Biochemistry and metabolism
Right arrow Functional genomics
Right arrow Oxidant stress
(Circulation Research. 2002;90:380.)
© 2002 American Heart Association, Inc.


Review

Applied Proteomics

Mitochondrial Proteins and Effect on Function

Mary F. Lopez, Simon Melov

From Proteome Systems (M.F.L.), Woburn, Mass; and Buck Institute for Age Research (S.M.), Novato, Calif.

Correspondence to Mary F. Lopez, PhD, Proteome Systems, 14 Gill St, Woburn, MA 01801. E-mail mary.lopez{at}proteomesystems.com

The identification of a majority of the polypeptides in mitochondria would be invaluable because they play crucial and diverse roles in many cellular processes and diseases. The endogenous production of reactive oxygen species (ROS) is a major limiter of life as illustrated by studies in which the transgenic overexpression in invertebrates of catalytic antioxidant enzymes results in increased lifespans. Mitochondria have received considerable attention as a principal source—and target—of ROS. Mitochondrial oxidative stress has been implicated in heart disease including myocardial preconditioning, ischemia/reperfusion, and other pathologies. In addition, oxidative stress in the mitochondria is associated with the pathogenesis of Alzheimer’s disease, Parkinson’s disease, prion diseases, and amyotrophic lateral sclerosis (ALS) as well as aging itself. The rapidly emerging field of proteomics can provide powerful strategies for the characterization of mitochondrial proteins. Current approaches to mitochondrial proteomics include the creation of detailed catalogues of the protein components in a single sample or the identification of differentially expressed proteins in diseased or physiologically altered samples versus a reference control. It is clear that for any proteomics approach prefractionation of complex protein mixtures is essential to facilitate the identification of low-abundance proteins because the dynamic range of protein abundance within cells has been estimated to be as high as 107. The opportunities for identification of proteins directly involved in diseases associated with or caused by mitochondrial dysfunction are compelling. Future efforts will focus on linking genomic array information to actual protein levels in mitochondria.


Key Words: proteomics • two-dimensional gel electrophoresis • mitochondria • reactive oxygen species • mass spectrometry




This article has been cited by other articles:


Home page
Circ. Res.Home page
E. McGregor and M. J. Dunn
Proteomics of the Heart: Unraveling Disease
Circ. Res., February 17, 2006; 98(3): 309 - 321.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
J. M. Cameron, T. Hurd, and B. H. Robinson
Computational identification of human mitochondrial proteins based on homology to yeast mitochondrially targeted proteins
Bioinformatics, May 1, 2005; 21(9): 1825 - 1830.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
K. Rezaul, L. Wu, V. Mayya, S.-I. Hwang, and D. Han
A Systematic Characterization of Mitochondrial Proteome from Human T Leukemia Cells
Mol. Cell. Proteomics, February 1, 2005; 4(2): 169 - 181.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. S. Friedman, M. F. Lopez, M. D. Fleming, A. Rivera, F. M. Martin, M. L. Welsh, A. Boyd, S. R. Doctrow, and S. J. Burakoff
SOD2-deficiency anemia: protein oxidation and altered protein expression reveal targets of damage, stress response, and antioxidant responsiveness
Blood, October 15, 2004; 104(8): 2565 - 2573.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Mayr, R. Siow, Y.-L. Chung, U. Mayr, J. R. Griffiths, and Q. Xu
Proteomic and Metabolomic Analysis of Vascular Smooth Muscle Cells: Role of PKC{delta}
Circ. Res., May 28, 2004; 94(10): e87 - e96.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. V. Turko, L. Li, K. S. Aulak, D. J. Stuehr, J.-Y. Chang, and F. Murad
Protein Tyrosine Nitration in the Mitochondria from Diabetic Mouse Heart: IMPLICATIONS TO DYSFUNCTIONAL MITOCHONDRIA IN DIABETES
J. Biol. Chem., September 5, 2003; 278(36): 33972 - 33977.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Tryoen-Toth, S. Richert, B. Sohm, M. Mine, C. Marsac, A. Van Dorsselaer, E. Leize, and C. Florentz
Proteomic Consequences of a Human Mitochondrial tRNA Mutation beyond the Frame of Mitochondrial Translation
J. Biol. Chem., June 27, 2003; 278(27): 24314 - 24323.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. L. Winslow and M. S. Boguski
Genome Informatics: Current Status and Future Prospects
Circ. Res., May 16, 2003; 92(9): 953 - 961.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
K Stuart-Smith
Demystified ... Nitric oxide
Mol. Pathol., December 1, 2002; 55(6): 360 - 366.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. D. E. Greene, K.-Y. Leung, R. Wait, S. Begum, M. J. Dunn, and A. J. Copp
Differential Protein Expression at the Stage of Neural Tube Closure in the Mouse Embryo
J. Biol. Chem., October 25, 2002; 277(44): 41645 - 41651.
[Abstract] [Full Text] [PDF]